Finance

Lists
Why is QTTB up 2,55%?
Dive Deeper
QTTB:NASDAQ
Q32 Bio Inc
8,44 US$
+2,55%
(+0,21) 1D
5 ოქტ, 15:04:25 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for QTTB...
Open
8,09 US$
High
8,56 US$
Low
7,81 US$
Mkt. cap
251,55 მლნ.
Avg. vol.
922,72 ათ.
Volume
611,91 ათ.
P/E ratio
2,82
52-wk high
23,57 US$
52-wk low
1,90 US$
EPS
2,99 US$
Beta
0,31
Shares outstanding
29,77 მლნ.
No. of employees
22
Open
8,09 US$
High
8,56 US$
Low
7,81 US$
Mkt. cap
251,55 მლნ.
Avg. vol.
922,72 ათ.
Volume
611,91 ათ.
P/E ratio
2,82
52-wk high
23,57 US$
52-wk low
1,90 US$
EPS
2,99 US$
Beta
0,31
Shares outstanding
29,77 მლნ.
No. of employees
22
News stories
From web sources and news partners
About Q32 Bio Inc
CEO-
Employees22
Founded2017
HeadquartersWaltham, მასაჩუსეტსი, ამერიკის შეერთებული შტატები
Sector-
Websiteq32bio.com
Analyst ratings
Based on 7 analysts giving stock ratings to QTTB in the past 3 months
Strong buy
Buy
7
Hold
0
Sell
0
12-month forecast
Based on 7 Wall Street analysts offering 12 month price targets for QTTB in the last 3 months.
Highest
Current 8,44 US$
59,00 US$ (+599,05%)
Average
38,86 US$ (+360,43%)
Lowest
29,00 US$ (+243,60%)
Analyst
Recommendation
Action
Price target
Projected
Date
Maury Raycroft
Jefferies
Buy
Maintained
29,00 US$
+243,6%
10/01/2026
Derek Archila
Wells Fargo
Buy
Reiterated
59,00 US$
+599,1%
10/01/2026
Kaveri Pohlman
Clear Street
Buy
Initiated
38,00 US$
+350,2%
10/01/2026
Joseph Pantginis
H.C. Wainwright
Buy
Reiterated
36,00 US$
+326,5%
09/30/2026
Judah Frommer
Morgan Stanley
Buy
Initiated
34,00 US$
+302,8%
08/24/2026
Jay Olson
Oppenheimer
Buy
Maintained
40,00 US$
+373,9%
08/06/2026
Joseph Catanzaro
Mizuho Securities
Buy
Reiterated
36,00 US$
+326,5%
07/13/2026
Richard Poland
Wells Fargo
Hold
Maintained
10,00 US$
+18,5%
05/28/2026
Unknown Analyst
Wells Fargo
Hold
Maintained
10,00 US$
+18,5%
05/28/2026
Unknown Analyst
Cantor Fitzgerald
Buy
Initiated
-
-
05/18/2026
Imogen Mansfield
Cantor Fitzgerald
Buy
Initiated
-
-
05/18/2026
Imogen Mansfield
Cantor Fitzgerald
Buy
Initiated
-
-
05/18/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
-
53,74 მლნ.
-
-
Cost of goods sold
3,56 მლნ.
3,32 მლნ.
3,22 მლნ.
4,26 მლნ.
Cost of revenue
3,56 მლნ.
3,32 მლნ.
3,22 მლნ.
4,26 მლნ.
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
4,02 მლნ.
4,54 მლნ.
4,50 მლნ.
4,86 მლნ.
Operating expense
4,02 მლნ.
4,54 მლნ.
4,50 მლნ.
4,86 მლნ.
Total operating expenses
7,58 მლნ.
7,86 მლნ.
7,72 მლნ.
9,12 მლნ.
Operating income
-7,58 მლნ.
45,88 მლნ.
-7,72 მლნ.
-9,12 მლნ.
Other non operating income
-12,00 ათ.
-12,00 ათ.
-79,00 ათ.
73,00 ათ.
EBT including unusual items
-7,39 მლნ.
57,73 მლნ.
-7,61 მლნ.
-8,95 მლნ.
EBT excluding unusual items
-7,39 მლნ.
46,07 მლნ.
-7,61 მლნ.
-8,80 მლნ.
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-7,39 მლნ.
57,73 მლნ.
-7,61 მლნ.
-8,95 მლნ.
Net profit margin
-
107,43%
-
-
Earnings per share
-
-
-
-
Interest and investment income
500,00 ათ.
400,00 ათ.
392,00 ათ.
446,00 ათ.
Interest expense
-300,00 ათ.
-200,00 ათ.
-200,00 ათ.
-200,00 ათ.
Net interest expenses
200,00 ათ.
200,00 ათ.
192,00 ათ.
246,00 ათ.
Depreciation and amortization charges
-
-
-
-
EBITDA
-7,49 მლნ.
45,97 მლნ.
-7,63 მლნ.
-9,03 მლნ.
Gain or loss from assets sale
-
-11,74 მლნ.
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google აპები